Trial Profile
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs Aciclovir (Primary)
- Indications Herpes labialis
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 01 Sep 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2012 New trial record